The COVID-19 pandemic has accelerated Government adoption of plans to implement the digitization of healthcare and the use of technology to store, share, and analyze healthcare information.

COVID-19 Pandemic Accelerated Demand for Hospitals and Clinical Labs: COVID-19 pandemic had a lot to do with the increased demand for hospitals. The shortage of hospitals led to the establishment of makeshift clinics and health centers around the world, and a similar situation had been found in Malaysia. The pandemic had shown the inability of various countries, including Malaysia, to cope with the pandemic situation, thereby increasing the need for hospital construction, further supporting the growth of the market in forthcoming years.

Genetic Testing: Growing interest in genetic testing is also driving the market. Genetic testing helps patients make important decisions about treatment and early detection of genetic problems. The high prevalence of refractory diseases in Malaysia, coupled with growing awareness of the importance of early diagnosis and accuracy of laboratory analysis, has led to an increase in patient visits to diagnostic laboratories for testing.

Adoption of Digital Pathology: Increased adoption of digital pathology has further increased the demand for clinical laboratory services. High prevalence of infectious diseases across Malaysia and growing awareness of early and accurate diagnosis are expected to drive the expansion of the clinical laboratory services market.

Government Initiatives: Investment by the government in multiple sectors and “My Health” by MOH are the government initiatives taken for the healthcare sector in Malaysia. A-Bio has raised a major revenue in funding at Clinipath Malaysia Sdn. Bhd. (Clinipass), promoting the digitalization of the medical industry in Malaysia.

Analysts at Ken Research in their latest publication “Malaysia Clinical Lab Market Outlook to 2027F- Medical tourism and government investment is driving the future of healthcare and clinical Tests in Malaysia” by Ken Research observed that Malaysia clinical lab market is in the growing phase. Growing medical infrastructure, increasing number of hospitals, and medical tourism are some of the factors that will contribute to Malaysia clinical lab market growth.

It is expected that Malaysia’s clinical lab market to grow at a robust CAGR for the period of 2022P-2027F.

Key Segments Covered

Malaysia Clinical Lab Market:

By Type of Lab
Organized Labs
Unorganized Labs
By Type of Ownership
Private
Public
By Mode of Tests
Walk-Ins
Doctor Referrals
Corporate Clients
Online Referrals
External referrals
By Type of Tests
Routine
Esoteric
Non-Laboratory
By Patient’s Age
0-20
20-40
40-60
60 and above

Request for Free Sample Report @ https://www.kenresearch.com/sample-report.php?Frmdetails=NTk2MjQx

By Region
West Malaysia
East Malaysia
By Payer
Out of pocket
Government
Private insurance
Corporates

Key Target Audience

Clinical Lab companies
Organized Clinical Laboratories
Unorganized Clinical Laboratories
Private Hospitals
Private Equity and Venture Capitalist
Industry Associations
Technology providers
Government Bodies & Regulating Authorities

Time Period Captured in the Report:

Historical Period: 2017-2022P
Base Year: 2022P
Forecast Period: 2022P– 2027F

Ask for Customization @ https://www.kenresearch.com/ask-customization.php?Frmdetails=NTk2MjQx

Companies Covered:

Diagnostics centers

BP Leader in Health Check
Pantai Premier Pathology
Gribbles
Lablink Medical Lab
Clinipath
Pathlab
Innoquest

Hospitals

Sunway Medical Centre
KPJ healthcare
Park City medical centre
Gleneagles Hospital
PANTAI Hospital

Online Healthcare Apps

Doctor2U medical Portal
Bookdoc Connect and Unite
Doctor Anywhere
Doc2US
Docquity

Visit @ https://www.kenresearch.com/healthcare/diagnostics/malaysia-clinical-lab-market-outlook-to-2027/596241-91.html

Key Topics Covered in the Report

Executive summary for Malaysia clinical lab market
Country Overview of Malaysia
Ecosystem of major entities in Business model of Malaysia clinical lab market 
Timeline of major operating in the Malaysia clinical lab market
Cross comparison of clinical laboratories market in Malaysia with south-east Asia
Malaysia Clinical Lab Market
Value chain analysis of clinical lab market
Malaysian healthcare system
Market overview of Malaysia healthcare market
Malaysia Clinical Lab Market Size, FY’2017-FY'2022P
Malaysia Clinical Lab Market Segmentation, FY'2022P
Segmentation by type of labs and ownership, region and by type of test, by patient age, mode of test, by payer
Industry Analysis
SWOT analysis of Malaysia clinical lab market
Trends and development in Malaysia clinical lab market
Growth driver in Malaysia clinical lab market
Technological innovation in Malaysia clinical lab market
Investment scenario in Malaysia clinical lab market
Issues and challenges in Malaysia clinical lab market
Government initiatives
Impact of covid-19 on Malaysia clinical lab market
Competitive Landscape of Malaysia Clinical Lab Market
Market Share of Major Players in Malaysia Clinical Lab Market
Market Positioning of Major Players in Malaysia Clinical Lab Market
Gartner Magic Quadrant
Cross-Comparison of Major Players in Malaysia Clinical Lab Market
Future Outlook for Market Size and Segmentation, FY’22P-FY’27F

For more information on the research report, refer to below link:

https://www.kenresearch.com/healthcare/diagnostics/malaysia-clinical-lab-market-outlook-to-2027/596241-91.html

Related Reports 

https://www.kenresearch.com/healthcare/diagnostics/indonesia-clinical-laboratory-market-outlook-to-2026/524049-91.html

https://www.kenresearch.com/healthcare/general-healthcare/philippines-clinical-laboratory-market-outlook-to-2027/596188-91.html